Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shweta Shah, Leon Raskin, David Cohan, Morganna Freeman & Omid Hamid. (2020) Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study. Current Medical Research and Opinion 36:1, pages 63-72.
Read now
Read now
Ying Zhang, Trong Kim Le, James W Shaw & Srividya Kotapati. (2015) Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma. ClinicoEconomics and Outcomes Research 7, pages 397-407.
Read now
Read now
Articles from other publishers (2)
Peter Mohr, Felix Kiecker, Virtudes Soriano, Olivier Dereure, Karmele Mujika, Philippe Saiag, Jochen Utikal, Rama Koneru, Caroline Robert, Florencia Cuadros, Matias Chacón, Rodrigo U Villarroel, Yana G Najjar, Lisa Kottschade, Eva M Couselo, Roy Koruth, Annie Guérin, Rebecca Burne, Raluca Ionescu-Ittu, Maurice Perrinjaquet & Jonathan S Zager. (2019) Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review. Melanoma Management 6:4, pages MMT33.
Crossref
Crossref
Ahmad Tarhini, Sameer R. Ghate, Raluca Ionescu-Ittu, Ameur M. Manceur, Briana Ndife, Philippe Jacques, François Laliberté, Antonio Nakasato, Rebecca Burne & Mei Sheng Duh. (2018) Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma. Melanoma Research 28:6, pages 618-628.
Crossref
Crossref